ARCHIVES

Fondaparinux Prevents DVT In Acutely III Medical Patients

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Summit Conference Reviews Leads In Leukemia, Lymphoma

January 8, 1982

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999

Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro

March 25, 1983

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.

March 12, 2004